你即將離開本站

並前往https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-pembrolizumab-first-tissuesite-agnostic-indication

FDA grants accelerated approval to pembrolizumab for first ...

On May 23, 2017, the U.S. Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA, Merck & Co.) ...

確定！ 回上一頁

查詢 「May 23」的人也找了：

  1. May 24
    2.
  2. May 25
    3.
  3. May 29
    4.
  4. May 26
    5.
  5. May 27
    6.
  6. May 30
    7.
  7. May 20
    8.
  8. May 22
    9.